Sessa Capital has significantly increased its stake in Sotera Health (SHC), acquiring over 10.6 million shares valued at approximately $175.8 million, as disclosed in a February 17, 2026 SEC filing. This transaction boosts Sessa’s total position in Sotera Health to nearly 7% of its reportable assets under management, reflecting a strategic bet on the company’s long-term growth potential in the healthcare services sector.
Sotera Health, which specializes in sterilization and lab testing services, has demonstrated robust revenue growth, reaching about $1.16 billion last year. However, the stock has faced downward pressure due to litigation risks, high leverage, and a recent influx of shares from a secondary offering, which has created a technical overhang. Despite these challenges, Sotera’s fundamentals remain strong, and its performance has outpaced the S&P 500 over the past year.
For market professionals, Sessa’s substantial investment signals confidence in Sotera’s resilience and growth trajectory. Investors should consider whether Sotera can navigate its current challenges while maintaining steady growth, as this could present a compelling opportunity for those looking to capitalize on potential market misperceptions.
Source: fool.com